Camatche, Dexy Jill B.

HRN: 23-06-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
AMPICILLIN 1GM (VIAL)
05/18/2023
05/25/2023
IV
2g
Q6
PROM X 16 Hours; G1P0 39 3/7 Weeks AOG By LMP; Young Primigravid
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: